Global Testosterone Undecanoate Market Growth 2024-2030

Publication ID:

LPI01250519

Publication Date:

February 7, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Testosterone Undecanoate market size was valued at US$ 551.7 million in 2023. With growing demand in downstream market, the Testosterone Undecanoate is forecast to a readjusted size of US$ 847.7 million by 2030 with a CAGR of 6.3% during review period.
The research report highlights the growth potential of the global Testosterone Undecanoate market. Testosterone Undecanoate are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Testosterone Undecanoate. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Testosterone Undecanoate market.
Testosterone undecanoate, sold under the brand names Nebido, Aveed, and Andriol among others, is an androgen and anabolic steroid (AAS) medication which is used mainly in the treatment of low testosterone levels in men. It is also used in hormone therapy for transgender men. It is taken by mouth two to three times per day with food or given by injection into muscle once every 12 weeks or so.
Key Features:
The report on Testosterone Undecanoate market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Testosterone Undecanoate market. It may include historical data, market segmentation by Type (e.g., Injection, Oral), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Testosterone Undecanoate market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Testosterone Undecanoate market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Testosterone Undecanoate industry. This include advancements in Testosterone Undecanoate technology, Testosterone Undecanoate new entrants, Testosterone Undecanoate new investment, and other innovations that are shaping the future of Testosterone Undecanoate.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Testosterone Undecanoate market. It includes factors influencing customer ' purchasing decisions, preferences for Testosterone Undecanoate product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Testosterone Undecanoate market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Testosterone Undecanoate market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Testosterone Undecanoate market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Testosterone Undecanoate industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Testosterone Undecanoate market.
Market Segmentation:
Testosterone Undecanoate market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Injection
Oral
Segmentation by application
Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bayer AG
Endo Pharmaceuticals
Merck Sharp & Dohme
Taro Pharmaceutical
Cipla
Zhejiang Xianju Pharmaceutical
Zhejiang Medicine Co.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Testosterone Undecanoate market?
What factors are driving Testosterone Undecanoate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Testosterone Undecanoate market opportunities vary by end market size?
How does Testosterone Undecanoate break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Testosterone Undecanoate Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Testosterone Undecanoate by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Testosterone Undecanoate by Country/Region, 2019, 2023 & 2030
2.2 Testosterone Undecanoate Segment by Type
2.2.1 Injection
2.2.2 Oral
2.3 Testosterone Undecanoate Sales by Type
2.3.1 Global Testosterone Undecanoate Sales Market Share by Type (2019-2024)
2.3.2 Global Testosterone Undecanoate Revenue and Market Share by Type (2019-2024)
2.3.3 Global Testosterone Undecanoate Sale Price by Type (2019-2024)
2.4 Testosterone Undecanoate Segment by Application
2.4.1 Primary Hypogonadism
2.4.2 Hypogonadotropic Hypogonadism
2.4.3 Late-Onset Hypogonadism
2.5 Testosterone Undecanoate Sales by Application
2.5.1 Global Testosterone Undecanoate Sale Market Share by Application (2019-2024)
2.5.2 Global Testosterone Undecanoate Revenue and Market Share by Application (2019-2024)
2.5.3 Global Testosterone Undecanoate Sale Price by Application (2019-2024)
3 Global Testosterone Undecanoate by Company
3.1 Global Testosterone Undecanoate Breakdown Data by Company
3.1.1 Global Testosterone Undecanoate Annual Sales by Company (2019-2024)
3.1.2 Global Testosterone Undecanoate Sales Market Share by Company (2019-2024)
3.2 Global Testosterone Undecanoate Annual Revenue by Company (2019-2024)
3.2.1 Global Testosterone Undecanoate Revenue by Company (2019-2024)
3.2.2 Global Testosterone Undecanoate Revenue Market Share by Company (2019-2024)
3.3 Global Testosterone Undecanoate Sale Price by Company
3.4 Key Manufacturers Testosterone Undecanoate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Testosterone Undecanoate Product Location Distribution
3.4.2 Players Testosterone Undecanoate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Testosterone Undecanoate by Geographic Region
4.1 World Historic Testosterone Undecanoate Market Size by Geographic Region (2019-2024)
4.1.1 Global Testosterone Undecanoate Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Testosterone Undecanoate Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Testosterone Undecanoate Market Size by Country/Region (2019-2024)
4.2.1 Global Testosterone Undecanoate Annual Sales by Country/Region (2019-2024)
4.2.2 Global Testosterone Undecanoate Annual Revenue by Country/Region (2019-2024)
4.3 Americas Testosterone Undecanoate Sales Growth
4.4 APAC Testosterone Undecanoate Sales Growth
4.5 Europe Testosterone Undecanoate Sales Growth
4.6 Middle East & Africa Testosterone Undecanoate Sales Growth
5 Americas
5.1 Americas Testosterone Undecanoate Sales by Country
5.1.1 Americas Testosterone Undecanoate Sales by Country (2019-2024)
5.1.2 Americas Testosterone Undecanoate Revenue by Country (2019-2024)
5.2 Americas Testosterone Undecanoate Sales by Type
5.3 Americas Testosterone Undecanoate Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Testosterone Undecanoate Sales by Region
6.1.1 APAC Testosterone Undecanoate Sales by Region (2019-2024)
6.1.2 APAC Testosterone Undecanoate Revenue by Region (2019-2024)
6.2 APAC Testosterone Undecanoate Sales by Type
6.3 APAC Testosterone Undecanoate Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Testosterone Undecanoate by Country
7.1.1 Europe Testosterone Undecanoate Sales by Country (2019-2024)
7.1.2 Europe Testosterone Undecanoate Revenue by Country (2019-2024)
7.2 Europe Testosterone Undecanoate Sales by Type
7.3 Europe Testosterone Undecanoate Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Testosterone Undecanoate by Country
8.1.1 Middle East & Africa Testosterone Undecanoate Sales by Country (2019-2024)
8.1.2 Middle East & Africa Testosterone Undecanoate Revenue by Country (2019-2024)
8.2 Middle East & Africa Testosterone Undecanoate Sales by Type
8.3 Middle East & Africa Testosterone Undecanoate Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Testosterone Undecanoate
10.3 Manufacturing Process Analysis of Testosterone Undecanoate
10.4 Industry Chain Structure of Testosterone Undecanoate
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Testosterone Undecanoate Distributors
11.3 Testosterone Undecanoate Customer
12 World Forecast Review for Testosterone Undecanoate by Geographic Region
12.1 Global Testosterone Undecanoate Market Size Forecast by Region
12.1.1 Global Testosterone Undecanoate Forecast by Region (2025-2030)
12.1.2 Global Testosterone Undecanoate Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Testosterone Undecanoate Forecast by Type
12.7 Global Testosterone Undecanoate Forecast by Application
13 Key Players Analysis
13.1 Bayer AG
13.1.1 Bayer AG Company Information
13.1.2 Bayer AG Testosterone Undecanoate Product Portfolios and Specifications
13.1.3 Bayer AG Testosterone Undecanoate Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Bayer AG Main Business Overview
13.1.5 Bayer AG Latest Developments
13.2 Endo Pharmaceuticals
13.2.1 Endo Pharmaceuticals Company Information
13.2.2 Endo Pharmaceuticals Testosterone Undecanoate Product Portfolios and Specifications
13.2.3 Endo Pharmaceuticals Testosterone Undecanoate Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Endo Pharmaceuticals Main Business Overview
13.2.5 Endo Pharmaceuticals Latest Developments
13.3 Merck Sharp & Dohme
13.3.1 Merck Sharp & Dohme Company Information
13.3.2 Merck Sharp & Dohme Testosterone Undecanoate Product Portfolios and Specifications
13.3.3 Merck Sharp & Dohme Testosterone Undecanoate Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Merck Sharp & Dohme Main Business Overview
13.3.5 Merck Sharp & Dohme Latest Developments
13.4 Taro Pharmaceutical
13.4.1 Taro Pharmaceutical Company Information
13.4.2 Taro Pharmaceutical Testosterone Undecanoate Product Portfolios and Specifications
13.4.3 Taro Pharmaceutical Testosterone Undecanoate Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Taro Pharmaceutical Main Business Overview
13.4.5 Taro Pharmaceutical Latest Developments
13.5 Cipla
13.5.1 Cipla Company Information
13.5.2 Cipla Testosterone Undecanoate Product Portfolios and Specifications
13.5.3 Cipla Testosterone Undecanoate Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Cipla Main Business Overview
13.5.5 Cipla Latest Developments
13.6 Zhejiang Xianju Pharmaceutical
13.6.1 Zhejiang Xianju Pharmaceutical Company Information
13.6.2 Zhejiang Xianju Pharmaceutical Testosterone Undecanoate Product Portfolios and Specifications
13.6.3 Zhejiang Xianju Pharmaceutical Testosterone Undecanoate Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Zhejiang Xianju Pharmaceutical Main Business Overview
13.6.5 Zhejiang Xianju Pharmaceutical Latest Developments
13.7 Zhejiang Medicine Co.
13.7.1 Zhejiang Medicine Co. Company Information
13.7.2 Zhejiang Medicine Co. Testosterone Undecanoate Product Portfolios and Specifications
13.7.3 Zhejiang Medicine Co. Testosterone Undecanoate Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Zhejiang Medicine Co. Main Business Overview
13.7.5 Zhejiang Medicine Co. Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂